Chai D - Search Results

1

Post-translational modifications of EZH2 in cancer.

Li Z, Li M, Wang D, Hou P, Chen X, Chu S, Chai D, Zheng J, Bai J. Li Z, et al. Among authors: chai d. Cell Biosci. 2020 Dec 11;10(1):143. doi: 10.1186/s13578-020-00505-0. Cell Biosci. 2020. PMID: 33308321 Free PMC article. Review.

2

The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines.

Li M, Zhang X, Lu Y, Meng S, Quan H, Hou P, Tong P, Chai D, Gao X, Zheng J, Tong X, Bai J. Li M, et al. Among authors: chai d. Cell Death Dis. 2020 Jan 16;11(1):31. doi: 10.1038/s41419-020-2225-6. Cell Death Dis. 2020. PMID: 31949131 Free PMC article.

3

IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy.

Chai D, Shi SY, Sobhani N, Ding J, Zhang Z, Jiang N, Wang G, Li M, Li H, Zheng J, Bai J. Chai D, et al. Cancers (Basel). 2022 Jun 9;14(12):2861. doi: 10.3390/cancers14122861. Cancers (Basel). 2022. PMID: 35740527 Free PMC article.

4

Using PAMPs and DAMPs as adjuvants in cancer vaccines.

Sun H, Hu W, Yan Y, Zhang Z, Chen Y, Yao X, Teng L, Wang X, Chai D, Zheng J, Wang G. Sun H, et al. Among authors: chai d. Hum Vaccin Immunother. 2021 Dec 2;17(12):5546-5557. doi: 10.1080/21645515.2021.1964316. Epub 2021 Sep 14. Hum Vaccin Immunother. 2021. PMID: 34520322 Free PMC article. Review.

5

iNKT: A new avenue for CAR-based cancer immunotherapy.

Liu Y, Wang G, Chai D, Dang Y, Zheng J, Li H. Liu Y, et al. Among authors: chai d. Transl Oncol. 2022 Mar;17:101342. doi: 10.1016/j.tranon.2022.101342. Epub 2022 Jan 18. Transl Oncol. 2022. PMID: 35063813 Free PMC article. Review.

6

The performance and perspectives of dendritic cell vaccines modified by immune checkpoint inhibitors or stimulants.

Ding J, Zheng Y, Wang G, Zheng J, Chai D. Ding J, et al. Among authors: chai d. Biochim Biophys Acta Rev Cancer. 2022 Sep;1877(5):188763. doi: 10.1016/j.bbcan.2022.188763. Epub 2022 Jul 21. Biochim Biophys Acta Rev Cancer. 2022. PMID: 35872287 Review.

7

ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells.

Liu N, Wu Z, Chen A, Chai D, Li L, Zhang L, Zheng J. Liu N, et al. Among authors: chai d. J Cell Mol Med. 2019 May;23(5):3520-3529. doi: 10.1111/jcmm.14251. Epub 2019 Mar 1. J Cell Mol Med. 2019. PMID: 30821058 Free PMC article.

8

The optimization system for preparation of TG1 competent cells and electrotransformation.

Chai D, Wang G, Fang L, Li H, Liu S, Zhu H, Zheng J. Chai D, et al. Microbiologyopen. 2020 Jul;9(7):e1043. doi: 10.1002/mbo3.1043. Epub 2020 May 11. Microbiologyopen. 2020. PMID: 32394632 Free PMC article.

9

Absent in melanoma 2 enhances anti-tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer.

Chai D, Qiu D, Zhang Z, Yuchen Shi S, Wang G, Fang L, Li H, Li H, Tian H, Zheng J. Chai D, et al. J Cell Mol Med. 2020 Sep;24(18):10744-10755. doi: 10.1111/jcmm.15697. Epub 2020 Jul 29. J Cell Mol Med. 2020. PMID: 32725966 Free PMC article.

10

Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma.

Chai D, Zhang Z, Shi SY, Qiu D, Zhang C, Wang G, Fang L, Li H, Tian H, Li H, Zheng J. Chai D, et al. Transl Oncol. 2021 Apr;14(4):101018. doi: 10.1016/j.tranon.2021.101018. Epub 2021 Jan 22. Transl Oncol. 2021. PMID: 33493800 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

422 results

Search Page